Company news

  • Comments
  • Print

Eli Lilly and Co. and its partner Germany-based Boehringer Ingelheim GmbH have won European market approval for linagliptin, a diabetes drug approved in the United States in May. The oral tablets will go by the name Trajenta in Europe, a slight alteration from the drug's U.S. trade name of Tradjenta. The drug helps patients with Type 2 diabetes reduce their blood sugar. The European Commission approved it for use on its own or with the standard diabetes pill metformin.

Indianapolis-based AMD Lasers LLC was acquired in June by Pennsylvania-based Dentsply International. AMD, founded in 2008 by Alan Miller, provides desktop laser technology to dentists at lower prices. It introduced its first product, called Picasso, in 2009.

Indiana University Health last week opened a kidney transplant telemedicine outreach clinic in Gary, one of seven it has around the state. The outreach clinic uses videoconferencing to conduct follow-up consultations with patients who have had a kidney transplant—so they don't have to travel to Indianapolis to see IU Health’s transplant surgeons face-to-face. The clinic is at Indiana University Northwest. IU Health’s other transplant outreach clinics, all established in the past three years, are in Avon, Carmel, Evansville, Fort Wayne, Merrillville and South Bend.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.